Also found in: Dictionary, Thesaurus, Financial, Acronyms, Encyclopedia, Wikipedia.

Saethre-Chotzen syndrome

A craniosynostosis syndrome (OMIM:101400) characterised by coronal synostosis, brachycephaly, low frontal hairline, facial asymmetry, hypertelorism, broad halluces and clinodactyly; about half of female patients with Saethre-Chotzen syndrome eventually develop breast cancer.

Molecular pathology
Caused by defects of TWIST1, which encodes a basic helix-loop-helix (bHLH) transcription factor, and FGFR2, which encodes fibroblast growth factor receptor.


n strain/counterstrain, an approach of applying pressure to certain tender points in the muscles or joints to decrease or remove the pain sensed at the point of palpation.
Enlarge picture
References in periodicals archive ?
MHI says SCS will only be run on Mitsubishi machines with its newer controls such as the MAC-VII system that is standard on its MSJ and MMJ series.
Youth movement: Based upon her remarkable effort in the SCS Zones, Renee Viveros is the future of Canyons Aquatics.
SCS is on the leading edge of operations technology, but SCS doesn't take you over the edge.
The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy, an SCS therapy that provides electrical pulses to the spinal cord to alleviate pain.
SCS specializes in providing competitive financing solutions for commercial transactions and real estate projects worldwide.
On SCS' 25th year of operations, Deepak Mistry, Marketing Manager at SCS, commented,
This acquisition represents a key foothold for SCS in the Asia Pacific markets and demonstrates our confidence in both the medical and non-medical growth prospects for our Company.
Our partnership with SCS will help us achieve our globalization goals," said Farzad Naimi, chairman, chief executive officer and a co-founder of LiteScape.
Looking forward, SCS officials said fourth-quarter revenue should rise between four and eight percent, putting per-share earnings at 14 to 19 cents.
Our agreement with SCS reflects the significant investments we are making to serve the needs of researchers exploring the therapeutic value of stem cells.